Literature DB >> 25878808

Crystal structure of the chalcone (E)-3-(furan-2-yl)-1-phenylprop-2-en-1-one.

Oscar F Vázquez-Vuelvas1, René A Enríquez-Figueroa1, Héctor García-Ortega2, Marcos Flores-Alamo2, Armando Pineda-Contreras1.   

Abstract

The title chalcone derivative, C13H10O2, adopts an E conformation about the C=C double bond. The mol-ecule is composed of a furanyl and a phenyl ring, bridged by an α,β-unsaturated carbonyl system, which are inclined to one another by 24.07 (7)°. In the crystal, mol-ecules are connected by weak C-H⋯O hydrogen bonds involving the carbonyl O atom acting as a trifurcated acceptor and C-H⋯π inter-actions, forming ribbons extending along the c-axis direction.

Entities:  

Keywords:  Claisen–Schmidt reaction; biological activity; chalcone derivative; crystal structure; hydrogen bonding; zigzag fashion.

Year:  2015        PMID: 25878808      PMCID: PMC4384596          DOI: 10.1107/S205698901500047X

Source DB:  PubMed          Journal:  Acta Crystallogr E Crystallogr Commun


Chemical context

The Claisen–Schmidt condensation reaction between substituted aceto­phenones and aryl aldehydes under basic con­ditions has been widely used to synthesize chalcone derivatives (Ghosh & Das, 2014 ▸; Robinson et al., 2013 ▸; Sharma et al., 2013 ▸; Tiwari et al., 2010 ▸). Chalcones, belonging to the flavonoid family, are an important class of natural products with widespread distribution in fruits, vegetables, spices and tea. These compounds are also often used as the precursors for the synthesis of various heterocyclic compounds (Chimenti et al., 2010 ▸; Elarfi & Al-Difar, 2012 ▸; Ghosh & Das, 2014 ▸; Hamada & Sharshira, 2011 ▸; Mahé et al., 2012 ▸; Sharma et al., 2013 ▸). Chemically, chalcones are 1,3-diaryl-2-propen-1-ones in which two aromatic rings, mainly benzene groups, are joined by a three-carbon bridge having a carbonyl moiety and α,β-unsaturation. Many studies have shown that chalcone derivatives exhibit a wide range of pharmacological activities, such as potential cytotoxic, anti­microbial, anti­viral, anti-inflammatory, anti-oxidant, anaesthetic, anti­malarial, anti­leishmanial, anti­tubercular, anti­tumor and anti­cancer activities (Boeck et al., 2006 ▸; Chimenti et al., 2010 ▸; Elarfi & Al-Difar, 2012 ▸; Hamada & Sharshira, 2011 ▸; Hsieh et al., 2000 ▸; Kumar et al., 2003 ▸; Sharma et al., 2013 ▸). These versatile compounds and their furan deriv­atives are often used as inter­mediates in the syntheses of mono­amine oxidase (MAO) inhibitors; moreover, the chalcones themselves have MAO inhibitory activity. Since the furan moiety represents a high π-electron density that contributes to the inter­action with the flavin nucleus of the co-factor in the inhibition of MAO, some furan-substituted chalcones, where an electron-rich heterocyclic oxygen replaces the benzene ring, have been synthesized to investigate their biological activity (Robinson et al., 2013 ▸; Shaikh et al., 2014 ▸; Sharma et al., 2013 ▸; Zheng et al., 2011 ▸). In view of the varied biological and pharmacological applications, we report herein on the synthesis and the mol­ecular and supra­molecular structure of the title compound, synthesized by a conventional base-catalysed Claisen–Schmidt condensation reaction.

Structural commentary

The symmetry-independent mol­ecule adopts an E conformation corresponding to an α,β-unsaturated non-planar structure, which bridges the pair of aromatic groups (Fig. 1 ▸). The two main planar groups, the furanyl and the phenyl rings, form a dihedral angle of 24.07 (7)°. In this context, the mol­ecular structure can be considered, for descriptive purposes, as two fragments basically described by the furanyl acryloyl and the benzoyl moieties. The benzoyl group shows a non-planar structure and presents rotation when observing the C2C1C7O2 torsion angle of 19.4 (2)°, denoting a marked deviation from planarity at the C1C7 bond, a single bond with rotational freedom. This deviation from planarity has also been reported previously in the crystal structure of an (E)-3-(4-hy­droxy­phen­yl)-1-(4-meth­oxy­phen­yl)-prop-2-en-1-one derivative, when observing the analogous reported inter­planar angle shown in the respectively 4-meth­oxy­benzoyl moiety (Qiu et al., 2006 ▸). In the same manner, the furanyl acryloyl entity presents a quasi-planar structure indicated by the two small torsion angles O2C7C8C9 [−5.4 (2)°] and C7C8C9—C10 [−176.31 (13)°], similar to the structure of the di­furanyl chalcone derivative (E)-1,3-di(2-fur­yl)-2-propen-1-one (Ocak Iskeleli et al., 2005b ▸). On the other hand, the mol­ecule inter­atomic linkage coincides with similar reported structures, specifically in the α,β-unsaturated entity of the title crystal (Harrison et al., 2006 ▸; Ocak Iskeleli et al., 2005a ▸,b ▸). As a result, the inter­atomic distances are in agreement with the conjugative nature, which is additionally supported by other described types of different weak inter­actions (vide infra) and also define the characteristic quasi-planar structure of chalcone derivatives.
Figure 1

The mol­ecular structure of the title compound, with displacement ellipsoids drawn at the 30% probability level.

Supra­molecular features

The crystal packing does not present geometrical parameters corresponding to classical hydrogen bonding (Gilli & Gilli, 2009 ▸; Steiner, 2002 ▸), neither intra- nor inter­molecular. In the crystal, centrosymmetrically related mol­ecules inter­act through a pair of weak hydrogen contacts (Table 1 ▸) with the C9 and C11 carbon atoms as donors and the O2 oxygen atom as a bifurcated acceptor, generating a ring with an (6) graph-set motif (Bernstein et al., 1995 ▸). The reciprocal inter­actions with the corresponding mol­ecule positioned in a head-to-tail mode generate the same ring motif and, as a consequence, an (10) ring is formed, describing a three-fused-ring system (Fig. 2 ▸). In addition, a weak hydrogen contact is present involving the C3 carbon atom as H-donor and the O2 oxygen atom acting, in this way, as a trifurcated acceptor. The propagation of this inter­action generates a ribbon along the c-axis direction (Fig. 2 ▸). The supra­molecular assembly is additionally supported by weak C—H⋯π inter­actions, implicating the phenyl and furanyl π systems (Fig. 3 ▸).
Table 1

Hydrogen-bond geometry (, )

Cg1 and Cg2 are the centroids of the O1/C10C13 furanyl ring and the C1C6 phenyl ring, respectively.

DHA DHHA D A DHA
C3H3O2i 0.952.513.457(2)151
C9H9O2ii 0.952.623.416(1)142
C11H11O2ii 0.952.513.277(2)138
C6H6Cg1iii 0.952.883.687(2)144
C13H13Cg2iv 0.952.713.519(9)143

Symmetry codes: (i) ; (ii) ; (iii) ; (iv) .

Figure 2

A partial packing diagram of the title compound, showing the hydrogen-bonded supra­molecular assembly via C—H⋯O inter­actions (blue dashed lines).

Figure 3

A partial packing diagram of the title compound, showing the C—H⋯π stacking inter­actions, depicted as blue and purple dotted lines for the C6—H6⋯Cg1 and C13—H13⋯Cg2 contacts, respectively. H atoms not involved in hydrogen-bonding inter­actions have been omitted for clarity.

Synthesis and crystallization

To a solution of NaOH (2.18 g, 55 mmol) in H2O/EtOH (30 ml, 2:1 v/v) was added pure aceto­phenone (5.2 g, 43 mmol), and stirring started; furfuraldehyde (4.6 g, 43 mmol) was then added at once. The reaction mixture was stirred for two hours and then kept in a refrigerator overnight. The resulting product was separated and then distilled under vacuum. The title compound was obtained as a yellow solid in 82% yield. Single-crystals suitable for X-ray determination were obtained by evaporation of an ethyl ether solution. M.p. 311–313 K; IR (ν, cm−1): 3123 (C—Halk), 3035 (C—Harom), 1658 (C=O), 1594, 1545, 1474 (C=C). 1H NMR (400 MHz, CDCl3, δ, p.p.m.): 8.04 (2H, dd), 7.61 (1H, d), 7.58 (1H, tt), 7.52 (2H, dd), 7.49 (1H, dd), 7.47 (1H, d), 6.72 (1H, dd), 6.51 (1H, dd). 13C NMR (100 MHz, CDCl3, δ, p.p.m.): 189.85 (C7), 151.69 (C10), 144.98 (C13), 138.16 (C1), 132.82 (C4), 130.72 (C9), 128.65 (C2,6), 128.47 (C3,5), 119.30 (C8), 116.33 (C11), 112.74 (C12). MS m/z: 199 (M +1); Analysis calculated for C13H10O2: C, 78.78; H, 5.05. Found: 78.80; H, 5.09.

Refinement details

Crystal data, data collection and structure refinement details are summarized in Table 2 ▸. H atoms attached to C atoms were placed in geometrically idealized positions and refined as riding on their parent atoms, with C—H = 0.95 Å and with U(H) = 1.2U(C).
Table 2

Experimental details

Crystal data
Chemical formulaC13H10O2
M r 198.21
Crystal system, space groupMonoclinic, P21/c
Temperature (K)130
a, b, c ()9.5296(7), 10.1383(7), 11.1595(7)
()103.922(6)
V (3)1046.49(13)
Z 4
Radiation typeMo K
(mm1)0.08
Crystal size (mm)0.50 0.45 0.32
 
Data collection
DiffractometerAgilent Xcalibur Atlas Gemini
Absorption correctionMulti-scan (CrysAlis PRO; Agilent, 2011)
T min, T max 0.781, 1
No. of measured, independent and observed [I > 2(I)] reflections8114, 2553, 1755
R int 0.019
(sin /)max (1)0.691
 
Refinement
R[F 2 > 2(F 2)], wR(F 2), S 0.045, 0.115, 1.04
No. of reflections2553
No. of parameters136
H-atom treatmentH-atom parameters constrained
max, min (e 3)0.11, 0.17

Computer programs: CrysAlis PRO (Agilent, 2011 ▸), SHELXS2013 and SHELXL2013 (Sheldrick, 2008 ▸, 2015 ▸), ORTEP-3 for Windows and WinGX (Farrugia, 2012 ▸), Mercury (Macrae et al., 2006 ▸) and DIAMOND (Brandenburg, 2012 ▸).

Crystal structure: contains datablock(s) global, I. DOI: 10.1107/S205698901500047X/rz5145sup1.cif Structure factors: contains datablock(s) I. DOI: 10.1107/S205698901500047X/rz5145Isup2.hkl Click here for additional data file. Supporting information file. DOI: 10.1107/S205698901500047X/rz5145Isup3.cml CCDC reference: 1042952 Additional supporting information: crystallographic information; 3D view; checkCIF report
C13H10O2F(000) = 416
Mr = 198.21Dx = 1.258 Mg m3
Monoclinic, P21/cMo Kα radiation, λ = 0.71073 Å
Hall symbol: -P 2ybcCell parameters from 2252 reflections
a = 9.5296 (7) Åθ = 3.8–29.4°
b = 10.1383 (7) ŵ = 0.08 mm1
c = 11.1595 (7) ÅT = 130 K
β = 103.922 (6)°Prism, colorless
V = 1046.49 (13) Å30.50 × 0.45 × 0.32 mm
Z = 4
Agilent Xcalibur Atlas Gemini diffractometer2553 independent reflections
Graphite monochromator1755 reflections with I > 2σ(I)
Detector resolution: 10.4685 pixels mm-1Rint = 0.019
ω scansθmax = 29.4°, θmin = 3.8°
Absorption correction: multi-scan (CrysAlis PRO; Agilent, 2011)h = −12→11
Tmin = 0.781, Tmax = 1k = −13→14
8114 measured reflectionsl = −14→14
Refinement on F20 restraints
Least-squares matrix: fullHydrogen site location: inferred from neighbouring sites
R[F2 > 2σ(F2)] = 0.045H-atom parameters constrained
wR(F2) = 0.115w = 1/[σ2(Fo2) + (0.0462P)2 + 0.1328P] where P = (Fo2 + 2Fc2)/3
S = 1.04(Δ/σ)max < 0.001
2553 reflectionsΔρmax = 0.11 e Å3
136 parametersΔρmin = −0.17 e Å3
Experimental. Absorption correction: CrysAlisPro, Agilent Technologies (Agilent, 2011) Empirical absorption correction using spherical harmonics, implemented in SCALE3 ABSPACK scaling algorithm.
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
xyzUiso*/Ueq
O10.96039 (10)0.15914 (10)0.09922 (8)0.0619 (3)
C10.65936 (13)−0.05129 (13)0.39220 (11)0.0465 (3)
O20.50969 (10)−0.03589 (12)0.19207 (8)0.0724 (3)
C70.62831 (14)−0.01269 (13)0.25976 (11)0.0499 (3)
C90.72460 (14)0.06998 (13)0.09060 (12)0.0498 (3)
H90.63220.0490.03960.06*
C80.74268 (14)0.04814 (14)0.21095 (11)0.0516 (3)
H80.83120.07240.26620.062*
C100.82803 (14)0.12119 (13)0.02963 (11)0.0477 (3)
C110.82469 (15)0.13668 (14)−0.09089 (12)0.0549 (3)
H110.74520.1182−0.15850.066*
C60.76975 (15)0.00494 (14)0.48148 (12)0.0551 (4)
H60.83090.06940.45870.066*
C120.96066 (16)0.18535 (14)−0.09817 (13)0.0587 (4)
H120.9910.2057−0.17110.07*
C20.57275 (16)−0.14617 (15)0.42759 (13)0.0605 (4)
H20.4966−0.18570.36750.073*
C131.03802 (17)0.19718 (16)0.01731 (14)0.0649 (4)
H131.13490.22810.03990.078*
C50.79115 (17)−0.03262 (17)0.60379 (13)0.0674 (4)
H50.86620.00690.66490.081*
C40.70484 (19)−0.12620 (19)0.63691 (15)0.0745 (5)
H40.72−0.15170.7210.089*
C30.59661 (19)−0.18335 (18)0.54951 (16)0.0740 (5)
H30.5375−0.24920.5730.089*
U11U22U33U12U13U23
O10.0544 (6)0.0759 (7)0.0512 (5)−0.0135 (5)0.0044 (4)0.0031 (5)
C10.0452 (7)0.0491 (7)0.0454 (7)0.0025 (5)0.0115 (5)−0.0024 (5)
O20.0504 (6)0.1151 (9)0.0482 (6)−0.0173 (6)0.0049 (4)−0.0038 (6)
C70.0457 (7)0.0577 (8)0.0448 (7)−0.0021 (6)0.0080 (5)−0.0071 (6)
C90.0469 (7)0.0538 (8)0.0471 (7)−0.0012 (6)0.0085 (5)−0.0031 (6)
C80.0476 (7)0.0602 (8)0.0455 (7)−0.0060 (6)0.0081 (5)−0.0030 (6)
C100.0470 (7)0.0475 (7)0.0468 (7)−0.0015 (5)0.0078 (5)−0.0010 (5)
C110.0556 (8)0.0610 (8)0.0473 (7)−0.0025 (7)0.0110 (6)−0.0014 (6)
C60.0585 (8)0.0595 (8)0.0467 (7)−0.0017 (6)0.0113 (6)−0.0054 (6)
C120.0610 (9)0.0609 (9)0.0582 (8)0.0001 (7)0.0217 (7)0.0050 (7)
C20.0546 (8)0.0661 (9)0.0605 (9)−0.0038 (7)0.0129 (6)0.0034 (7)
C130.0533 (8)0.0721 (10)0.0702 (10)−0.0104 (7)0.0164 (7)0.0086 (8)
C50.0675 (10)0.0847 (11)0.0461 (8)0.0074 (8)0.0060 (7)−0.0061 (8)
C40.0788 (11)0.0943 (13)0.0523 (9)0.0182 (10)0.0193 (8)0.0168 (9)
C30.0742 (11)0.0777 (11)0.0742 (11)0.0007 (8)0.0256 (9)0.0199 (9)
O1—C131.3627 (17)C11—H110.95
O1—C101.3678 (15)C6—C51.3840 (19)
C1—C21.3855 (19)C6—H60.95
C1—C61.3857 (18)C12—C131.327 (2)
C1—C71.4882 (17)C12—H120.95
O2—C71.2218 (15)C2—C31.377 (2)
C7—C81.4664 (18)C2—H20.95
C9—C81.3308 (17)C13—H130.95
C9—C101.4236 (18)C5—C41.364 (2)
C9—H90.95C5—H50.95
C8—H80.95C4—C31.366 (2)
C10—C111.3468 (18)C4—H40.95
C11—C121.407 (2)C3—H30.95
C13—O1—C10105.91 (10)C5—C6—H6119.9
C2—C1—C6118.81 (12)C1—C6—H6119.9
C2—C1—C7118.43 (11)C13—C12—C11106.25 (13)
C6—C1—C7122.76 (12)C13—C12—H12126.9
O2—C7—C8120.74 (12)C11—C12—H12126.9
O2—C7—C1119.78 (12)C3—C2—C1120.25 (14)
C8—C7—C1119.44 (11)C3—C2—H2119.9
C8—C9—C10127.34 (12)C1—C2—H2119.9
C8—C9—H9116.3C12—C13—O1111.18 (13)
C10—C9—H9116.3C12—C13—H13124.4
C9—C8—C7121.16 (12)O1—C13—H13124.4
C9—C8—H8119.4C4—C5—C6120.22 (15)
C7—C8—H8119.4C4—C5—H5119.9
C11—C10—O1109.34 (12)C6—C5—H5119.9
C11—C10—C9131.84 (12)C5—C4—C3120.17 (14)
O1—C10—C9118.76 (11)C5—C4—H4119.9
C10—C11—C12107.32 (12)C3—C4—H4119.9
C10—C11—H11126.3C4—C3—C2120.40 (16)
C12—C11—H11126.3C4—C3—H3119.8
C5—C6—C1120.15 (14)C2—C3—H3119.8
C2—C1—C7—O219.4 (2)C9—C10—C11—C12−176.65 (14)
C6—C1—C7—O2−159.66 (14)C2—C1—C6—C5−0.7 (2)
C2—C1—C7—C8−158.15 (13)C7—C1—C6—C5178.37 (13)
C6—C1—C7—C822.74 (19)C10—C11—C12—C13−0.29 (17)
C10—C9—C8—C7−176.31 (13)C6—C1—C2—C30.0 (2)
O2—C7—C8—C9−5.4 (2)C7—C1—C2—C3−179.11 (14)
C1—C7—C8—C9172.14 (12)C11—C12—C13—O1−0.03 (18)
C13—O1—C10—C11−0.50 (16)C10—O1—C13—C120.33 (17)
C13—O1—C10—C9177.07 (12)C1—C6—C5—C40.8 (2)
C8—C9—C10—C11173.72 (14)C6—C5—C4—C3−0.1 (2)
C8—C9—C10—O1−3.2 (2)C5—C4—C3—C2−0.7 (3)
O1—C10—C11—C120.49 (16)C1—C2—C3—C40.7 (3)
D—H···AD—HH···AD···AD—H···A
C3—H3···O2i0.952.513.457 (2)151
C9—H9···O2ii0.952.623.416 (1)142
C11—H11···O2ii0.952.513.277 (2)138
C6—H6···Cg1iii0.952.883.687 (2)144
C13—H13···Cg2iv0.952.713.519 (9)143
  9 in total

1.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

2.  Synthesis and anti-bacterial activity of some heterocyclic chalcone derivatives bearing thiofuran, furan, and quinoline moieties.

Authors:  Chang-Ji Zheng; Sheng-Ming Jiang; Zhen-Hua Chen; Bai-Jun Ye; Hu-Ri Piao
Journal:  Arch Pharm (Weinheim)       Date:  2011-09-02       Impact factor: 3.751

3.  Enantioselective synthesis of bio-relevant 3,5-diaryl pyrazolines.

Authors:  Olivier Mahé; Isabelle Dez; Vincent Levacher; Jean-François Brière
Journal:  Org Biomol Chem       Date:  2012-04-11       Impact factor: 3.876

4.  Selected furanochalcones as inhibitors of monoamine oxidase.

Authors:  Sarel J Robinson; Jacobus P Petzer; Anél Petzer; Jacobus J Bergh; Anna C U Lourens
Journal:  Bioorg Med Chem Lett       Date:  2013-06-28       Impact factor: 2.823

5.  Synthesis and anti-inflammatory effect of chalcones.

Authors:  H K Hsieh; L T Tsao; J P Wang; C N Lin
Journal:  J Pharm Pharmacol       Date:  2000-02       Impact factor: 3.765

6.  Design, synthesis, and evaluation of novel boronic-chalcone derivatives as antitumor agents.

Authors:  Srinivas K Kumar; Erin Hager; Catherine Pettit; Hallur Gurulingappa; Nancy E Davidson; Saeed R Khan
Journal:  J Med Chem       Date:  2003-07-03       Impact factor: 7.446

7.  A new series of flavones, thioflavones, and flavanones as selective monoamine oxidase-B inhibitors.

Authors:  Franco Chimenti; Rossella Fioravanti; Adriana Bolasco; Paola Chimenti; Daniela Secci; Francesca Rossi; Matilde Yáñez; Francisco Orallo; Francesco Ortuso; Stefano Alcaro; Roberto Cirilli; Rosella Ferretti; M Luisa Sanna
Journal:  Bioorg Med Chem       Date:  2010-01-04       Impact factor: 3.641

8.  Crystal structure refinement with SHELXL.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr C Struct Chem       Date:  2015-01-01       Impact factor: 1.172

9.  Synthesis and antimicrobial evaluation of some heterocyclic chalcone derivatives.

Authors:  Nagwa Mohamed Mahrous Hamada; Essam Mohamed Sharshira
Journal:  Molecules       Date:  2011-03-09       Impact factor: 4.411

  9 in total
  1 in total

1.  Synthesis, Structure and In Vitro Anti-Trypanosomal Activity of Non-Toxic Arylpyrrole-Based Chalcone Derivatives.

Authors:  Ayanda I Zulu; Ogunyemi O Oderinlo; Cuan Kruger; Michelle Isaacs; Heinrich C Hoppe; Vincent J Smith; Clinton G L Veale; Setshaba D Khanye
Journal:  Molecules       Date:  2020-04-04       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.